BioSpace News Archive

The U.S. Food and Drug Administration has authorized marketing of the Hominis Surgical System, a new robotically-assisted surgical device (RASD) that can help facilitate transvaginal hysterectomy in certain patients.

Innova Medical Group, Inc., the world’s largest manufacturer of rapid antigen test kits and leader in COVID-19 testing solutions globally, announced today the appointment of Sean Rogers as Chairman of Innova Medical Group, and Todd Malan, M.D., as Innova’s Chief Medical Officer.

Lasso, the first and only omni-channel platform for healthcare marketing and analytics, and Xandr today announced a strategic partnership to simplify the way marketers plan, activate, and measure their Healthcare Provider (HCP) and Direct-to-Consumer (DTC) campaigns.

OmniTier announced that its CompStor® family now supports mitochondrial analysis in both its secondary and tertiary analysis appliances.

The Canadian Cancer Society and Ludovick Bourgeois will take advantage of the month of March, Colorectal Cancer Awareness Month, to educate Quebecers 50 to 74 years old about a test that can detect colon cancer early on and encourage them to speak to their doctori about taking the test every two years, either face-to-face or by virtual consultation during the pandemic.

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), allowing the company to market its new QuickVue® At-Home COVID-19 Test

Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, introduces the KidneyCare:365 program focused on providing care coordination to people living with chronic kidney disease (CKD) working in close partnership with their physicians and physician networks including InterWell Health.

Valo Health LLC (Valo), the technology company working to transform the drug discovery and development process and accelerate the creation of life-changing drugs, today announced the appointment of Nish Lathia as Chief Product Officer (CPO), a newly established executive leadership position at the company.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced that the Company will be participating in the Cowen 41st Annual Health Care Conference,